A
quick review of the cumulative research conducted on the efficacy of
HCQ, Ivermectin, as well as Vitamin D, compared to the CDC’s recommended
drugs Remdesivir and Molnupiravir presents a stark picture America’s
pandemic response policies favor profit over health.
Hydroxychloroquine
- 606 studies, 419 peer-reviewed comparing treatment with a control for Covid-19
- Trials involved 8,646 scientists and over 591,000 patients
- 66% improvement in 38 early treatment trials
- 76% improvement in 17 early stage infection treatment mortality results
- 22% improvement in 270 late stage infection treatment trials (patients in serious condition)
| 
|
Tragic of Suppressing Effective COVID-19 Treatments